×

Magnesium plus interactive agent delivery

  • US 6,887,492 B2
  • Filed: 12/14/2001
  • Issued: 05/03/2005
  • Est. Priority Date: 12/14/2000
  • Status: Expired due to Term
First Claim
Patent Images

1. A unit dosage form tablet or capsule composition for oral administration comprisinga) an enteric coated magnesium component having an active ingredient consisting essentially of one or more magnesium compounds, wherein said enteric coating is a polymeric release-controlling agent which substantially prevents release of said one or more magnesium compounds until passage out of the stomach and into the intestine of the host, and wherein said release-controlling agent has a pH dissolution point of from about 5 to about 8;

  • and b) an uncoated calcium component having an active ingredient consisting essentially of one or more calcium compounds;

    wherein substantially all of said calcium component is released before passage into said intestine of said host, and wherein the ratio of said calcium component to said magnesium component is from 1;

    5 to 5;

    1.

View all claims
  • 16 Assignments
Timeline View
Assignment View
    ×
    ×